HomeNDC LookupRxCUI directory › RxCUI 1047511

Doxapram hydrochloride 20 MG/ML Injectable Solution [Dopram] — RxCUI 1047511

RxNorm drug concept · Semantic branded drug
RxCUI 1047511 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1047511
Official nameDoxapram hydrochloride 20 MG/ML Injectable Solution [Dopram]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDopram 20 MG/ML Injectable Solution; Dopram 400 MG in 20 ML Injectable Solution; Dopram 400 MG per 20 ML Injectable Solution; DOPRAM-V 20 MG/ML Injectable Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Doxapram hydrochloride 20 MG/ML Injectable Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxapram hydrochloride 20 MG/ML Injectable Solution [Dopram] RxCUI 1047511

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxapram 3637
    • Doxapram hydrochloride 82011
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dopram 202987
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxapram Injectable Solution 371960
    • Doxapram hydrochloride Injectable Solution 2647748
    • Doxapram Injectable Product 1160763
    • Doxapram hydrochloride Injectable Product 2660358
    • Doxapram Injectable Solution [Dopram] 362601
    • Doxapram hydrochloride Injectable Solution [Dopram] 2657570
    • Dopram Injectable Product 1175288
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxapram hydrochloride 20 MG/ML Injectable Solution SCD · 1047087
  • Doxapram hydrochloride 20 MG/ML SCDC · 1047086
  • Doxapram Injectable Solution SCDF · 371960
  • Doxapram hydrochloride Injectable Solution SCDFP · 2647748
  • Doxapram Injectable Product SCDG · 1160763
  • Doxapram hydrochloride Injectable Product SCDGP · 2660358

Brand-Name Concepts

  • Doxapram hydrochloride 20 MG/ML [Dopram] SBDC · 1047510
  • Doxapram Injectable Solution [Dopram] SBDF · 362601
  • Doxapram hydrochloride Injectable Solution [Dopram] SBDFP · 2657570
  • Dopram Injectable Product SBDG · 1175288
  • Dopram BN · 202987

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1047511 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00641-6018-01 20 mL in 1 VIAL (0641-6018-01) Dopram Hikma Pharmaceuticals USA Inc. 1965-06-23
00641-6018-06 6 VIAL in 1 CARTON (0641-6018-06) / 20 mL in 1 VIAL (0641-6... Dopram Hikma Pharmaceuticals USA Inc. 1965-06-23
Observed labelers: Hikma Pharmaceuticals USA Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.